Sökning: id:"swepub:oai:gup.ub.gu.se/108469" >
Autoantibodies in a...
Autoantibodies in atrial fibrillation: actor, biomaker or bystander?
-
Baba, Akiyasu (författare)
-
- Fu, Michael, 1963 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
-
(creator_code:org_t)
- 2009-07-07
- 2008
- Engelska.
-
Ingår i: Autoimmunity. - : Informa UK Limited. - 1607-842X .- 0891-6934. ; 41:6, s. 470-2
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Atrial fibrillation (AF) is one of the most common arrhythmias in patients with congestive heart failure, although the underlying mechanism has still to be determined. There is increasing evidence to suggest that autoimmunity may play an important role in the pathogenesis of AF. To date, at least three types of autoantibody have been found in AF: the anti-myosin heavy chain autoantibody, the anti-M2 muscarinic receptor autoantibody and the anti-heat shock protein autoantibody. The question is: are these autoantibodies actors, biomakers or merely bystanders? How much knowledge do we have?
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Fysiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Physiology (hsv//eng)
Nyckelord
- Atrial Fibrillation
- immunology
- metabolism
- Autoantibodies
- immunology
- Autoimmunity
- Biological Markers
- metabolism
- Cardiac Myosins
- immunology
- Heat-Shock Proteins
- immunology
- Humans
- Myosin Heavy Chains
- immunology
- Receptor
- Muscarinic M2
- immunology
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas